drugset / Trial / NCT03175913
Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion
RandomizedParallel-groupDouble-blindTreatment
Summary
This was a single-blind, randomized controlled trial. Sixty-six patients who underwent caudal epidural injection were randomized into the vapocoolant spray group or local infiltration group. Before the insertion of a 20-gauge spinal needle, the subcutaneous tissue was infiltrated with 3 ml of 2% lidocaine in the local infiltration group and vapocoolant spray was applied just before the spinal needle insertion in the spray group. 100-mm visual analog scale to evaluate the pain intensity of spinal needle insertion and a five-point Likert scale for patient satisfaction and preference for repeated use were compared between the two groups.
Timeline
- Start
- 2014-06-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 % | Subcutaneous |
| Subject | Lidocaine | Other / unclassified | 3 ml | Subcutaneous |
Indications
No indication recorded.